Annual CFF
$514.32 M
+$422.45 M+459.83%
December 31, 2024
Summary
- As of March 12, 2025, PRAX annual cash flow from financing activities is $514.32 million, with the most recent change of +$422.45 million (+459.83%) on December 31, 2024.
- During the last 3 years, PRAX annual CFF has risen by +$406.74 million (+378.06%).
- PRAX annual CFF is now at all-time high.
Performance
PRAX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$113.77 M
+$112.33 M+7822.49%
December 31, 2024
Summary
- As of March 12, 2025, PRAX quarterly cash flow from financing activities is $113.77 million, with the most recent change of +$112.33 million (+7822.49%) on December 31, 2024.
- Over the past year, PRAX quarterly CFF has increased by +$112.33 million (+7822.49%).
- PRAX quarterly CFF is now -47.42% below its all-time high of $216.36 million, reached on June 30, 2024.
Performance
PRAX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$514.32 M
+$109.64 M+27.09%
December 31, 2024
Summary
- As of March 12, 2025, PRAX TTM cash flow from financing activities is $514.32 million, with the most recent change of +$109.64 million (+27.09%) on December 31, 2024.
- Over the past year, PRAX TTM CFF has increased by +$109.64 million (+27.09%).
- PRAX TTM CFF is now at all-time high.
Performance
PRAX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PRAX Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +459.8% | +7822.5% | +27.1% |
3 y3 years | +378.1% | +529.6% | +1782.2% |
5 y5 years | +751.7% | +529.6% | +1782.2% |
PRAX Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +4814.7% | -47.4% | -100.0% | at high | +5236.4% |
5 y | 5-year | at high | +4814.7% | -47.4% | +479.2% | at high | +1814.4% |
alltime | all time | at high | +4814.7% | -47.4% | +479.2% | at high | +1814.4% |
Praxis Precision Medicines Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $514.32 M(+459.8%) | $113.77 M(+7822.5%) | $514.32 M(+27.1%) |
Sep 2024 | - | $1.44 M(-99.3%) | $404.68 M(+0.4%) |
Jun 2024 | - | $216.36 M(+18.4%) | $403.25 M(+57.2%) |
Mar 2024 | - | $182.76 M(+4329.4%) | $256.56 M(+179.3%) |
Dec 2023 | $91.87 M(+777.9%) | $4.13 M(>+9900.0%) | $91.87 M(-1.4%) |
Sep 2023 | - | $0.00(-100.0%) | $93.13 M(-3.5%) |
Jun 2023 | - | $69.67 M(+285.6%) | $96.50 M(+253.1%) |
Mar 2023 | - | $18.07 M(+235.4%) | $27.33 M(+161.1%) |
Dec 2022 | $10.46 M | $5.39 M(+60.1%) | $10.46 M(-18.2%) |
Sep 2022 | - | $3.37 M(+567.7%) | $12.79 M(+32.7%) |
Jun 2022 | - | $504.00 K(-58.3%) | $9.64 M(-91.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | $1.21 M(-84.3%) | $108.52 M(+0.9%) |
Dec 2021 | $107.59 M(-64.7%) | $7.71 M(+3538.2%) | $107.59 M(-64.4%) |
Sep 2021 | - | $212.00 K(-99.8%) | $301.94 M(-26.5%) |
Jun 2021 | - | $99.39 M(>+9900.0%) | $410.63 M(+22.7%) |
Mar 2021 | - | $276.00 K(-99.9%) | $334.69 M(+9.9%) |
Dec 2020 | $304.42 M(+404.1%) | $202.06 M(+85.5%) | $304.42 M(+197.4%) |
Sep 2020 | - | $108.91 M(+364.5%) | $102.35 M(-1661.7%) |
Jun 2020 | - | $23.45 M(-178.2%) | -$6.55 M(-78.2%) |
Mar 2020 | - | -$30.00 M | -$30.00 M |
Dec 2019 | $60.39 M(+59.7%) | - | - |
Dec 2018 | $37.80 M | - | - |
FAQ
- What is Praxis Precision Medicines annual cash flow from financing activities?
- What is the all time high annual CFF for Praxis Precision Medicines?
- What is Praxis Precision Medicines annual CFF year-on-year change?
- What is Praxis Precision Medicines quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Praxis Precision Medicines?
- What is Praxis Precision Medicines quarterly CFF year-on-year change?
- What is Praxis Precision Medicines TTM cash flow from financing activities?
- What is the all time high TTM CFF for Praxis Precision Medicines?
- What is Praxis Precision Medicines TTM CFF year-on-year change?
What is Praxis Precision Medicines annual cash flow from financing activities?
The current annual CFF of PRAX is $514.32 M
What is the all time high annual CFF for Praxis Precision Medicines?
Praxis Precision Medicines all-time high annual cash flow from financing activities is $514.32 M
What is Praxis Precision Medicines annual CFF year-on-year change?
Over the past year, PRAX annual cash flow from financing activities has changed by +$422.45 M (+459.83%)
What is Praxis Precision Medicines quarterly cash flow from financing activities?
The current quarterly CFF of PRAX is $113.77 M
What is the all time high quarterly CFF for Praxis Precision Medicines?
Praxis Precision Medicines all-time high quarterly cash flow from financing activities is $216.36 M
What is Praxis Precision Medicines quarterly CFF year-on-year change?
Over the past year, PRAX quarterly cash flow from financing activities has changed by +$112.33 M (+7822.49%)
What is Praxis Precision Medicines TTM cash flow from financing activities?
The current TTM CFF of PRAX is $514.32 M
What is the all time high TTM CFF for Praxis Precision Medicines?
Praxis Precision Medicines all-time high TTM cash flow from financing activities is $514.32 M
What is Praxis Precision Medicines TTM CFF year-on-year change?
Over the past year, PRAX TTM cash flow from financing activities has changed by +$109.64 M (+27.09%)